Terms: = Prostate cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
192 results:
1. Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma.
Wang X; Sun J; Liu Y; Lin Z; Jiang X; Ye Y; Lv C; Lian X; Xu W; Luo S; Liao S; Chen Z; Wang S
Int J Cancer; 2024 May; 154(9):1639-1651. PubMed ID: 38212905
[TBL] [Abstract] [Full Text] [Related]
2. The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
3. Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
[TBL] [Abstract] [Full Text] [Related]
5. Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Lang B; Cao C; Zhao X; Wang Y; Cao Y; Zhou X; Zhao T; Wang Y; Liu T; Liang W; Hu Z; Tian X; Zhang J; Yan Y
Eur J Med Res; 2023 Jul; 28(1):239. PubMed ID: 37461056
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Values of Gene Copy Number Alterations in prostate cancer.
Alfahed A; Ebili HO; Almoammar NE; Alasiri G; AlKhamees OA; Aldali JA; Al Othaim A; Hakami ZH; Abdulwahed AM; Waggiallah HA
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239316
[TBL] [Abstract] [Full Text] [Related]
7. 7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells.
Abolhassani Y; Mirzaei S; Nejabat M; Talebian S; Gholamhosseinian H; Iranshahi M; Rassouli FB; Jamialahmadi K
Mol Biol Rep; 2023 Jul; 50(7):5709-5717. PubMed ID: 37217617
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic prostate cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
Hwang J; Shi X; Elliott A; Arnoff TE; McGrath J; Xiu J; Walker P; Bergom HE; Day A; Ahmed S; Tape S; Makovec A; Ali A; Shaker RM; Toye E; Passow R; Lozada JR; Wang J; Lou E; Mouw KW; Carneiro BA; Heath EI; McKay RR; Korn WM; Nabhan C; Ryan CJ; Antonarakis ES
Clin Cancer Res; 2023 Jul; 29(14):2702-2713. PubMed ID: 37126020
[TBL] [Abstract] [Full Text] [Related]
9. Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone.
Ono A; Hashimoto T; Shishido T; Hirasawa Y; Satake N; Namiki K; Saito K; Ohno Y
Int J Clin Oncol; 2023 May; 28(5):716-723. PubMed ID: 36961616
[TBL] [Abstract] [Full Text] [Related]
10. EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder cancer undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.
Akdemir E; Sweegers MG; Vrieling A; Rundqvist H; Meijer RP; Leliveld-Kors AM; van der Heijden AG; Rutten VC; Koldewijn EL; Bos SD; Wijburg CJ; Marcelissen TAT; Bongers BC; Retèl VP; van Harten WH; May AM; Groen WG; Stuiver MM
BMJ Open; 2023 Mar; 13(3):e071304. PubMed ID: 36882246
[TBL] [Abstract] [Full Text] [Related]
11. Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study.
Sanghavi A; Srivatsa A; Adiga D; Chopra A; Lobo R; Kabekkodu SP; Gadag S; Nayak U; Sivaraman K; Shah A
F1000Res; 2022; 11():1563. PubMed ID: 36761830
[No Abstract] [Full Text] [Related]
12. The Small Molecule Antagonist KCI807 Disrupts Association of the Amino-Terminal Domain of the Androgen Receptor with ELK1 by Modulating the Adjacent DNA Binding Domain.
Soave C; Ducker C; Islam N; Kim S; Yurgelevic S; Nicely NI; Pardy L; Huang Y; Shaw PE; Auner G; Dickson A; Ratnam M
Mol Pharmacol; 2023 Apr; 103(4):211-220. PubMed ID: 36720643
[TBL] [Abstract] [Full Text] [Related]
13. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials.
Cornetta K; Yao J; House K; Duffy L; Adusumilli PS; Beyer R; Booth C; Brenner M; Curran K; Grilley B; Heslop H; Hinrichs CS; Kaplan RN; Kiem HP; Kochenderfer J; Kohn DB; Mailankody S; Norberg SM; O'Cearbhaill RE; Pappas J; Park J; Ramos C; Ribas A; Rivière I; Rosenberg SA; Sauter C; Shah NN; Slovin SF; Thrasher A; Williams DA; Lin TY
Mol Ther; 2023 Mar; 31(3):801-809. PubMed ID: 36518078
[TBL] [Abstract] [Full Text] [Related]
14. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy.
Xu G; Li JH; Xiang LH; Yang B; Chen YC; Sun YK; Zhao BH; Wu J; Sun LP; Xu HX
Asian J Androl; 2023; 25(3):410-415. PubMed ID: 36348578
[TBL] [Abstract] [Full Text] [Related]
15. The 17-Gene Genomic prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy in Men With Clinically Localized prostate cancer.
Janes JL; Boyer MJ; Bennett JP; Thomas VM; De Hoedt AM; Edwards V DK; Singla PK; Abran JM; Aboushwareb T; Salama JK; Freedland SJ
Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):120-131. PubMed ID: 36306979
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.
Mahbub AA; Aslam A; Elzubier ME; El-Boshy M; Abdelghany AH; Ahmad J; Idris S; Almaimani R; Alsaegh A; El-Readi MZ; Baghdadi MA; Refaat B
Front Endocrinol (Lausanne); 2022; 13():941834. PubMed ID: 36263327
[TBL] [Abstract] [Full Text] [Related]
17. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes.
Jiménez-Vacas JM; Montero-Hidalgo AJ; Gómez-Gómez E; Sáez-Martínez P; Fuentes-Fayos AC; Closa A; González-Serrano T; Martínez-López A; Sánchez-Sánchez R; López-Casas PP; Sarmento-Cabral A; Olmos D; Eyras E; Castaño JP; Gahete MD; Luque RM
Transl Res; 2023 Mar; 253():68-79. PubMed ID: 36089245
[TBL] [Abstract] [Full Text] [Related]
18. Effect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective Trial.
Student V; Tudos Z; Studentova Z; Cesak O; Studentova H; Repa V; Purova D; Student V
Eur Urol; 2023 Feb; 83(2):154-162. PubMed ID: 36041934
[TBL] [Abstract] [Full Text] [Related]
19. Glyphosate disturbs various epigenetic processes in vitro and in vivo - A mini review.
Bukowska B; Woźniak E; Sicińska P; Mokra K; Michałowicz J
Sci Total Environ; 2022 Dec; 851(Pt 2):158259. PubMed ID: 36030868
[TBL] [Abstract] [Full Text] [Related]
20. cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
[TBL] [Abstract] [Full Text] [Related]
[Next]
